Intervention

Emtricitabine/tenofovir disoproxil fumarate (F/TDF)

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions2

Lead sponsors shown1

Clinical trials

3 shown

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV PreventionNCT07473778 · 2026-03-17

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)NCT06513312 · 2024-10-07

ACTIVE_NOT_RECRUITING

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)NCT06101342 · 2023-12-13

ACTIVE_NOT_RECRUITING

Common conditions

Pre-Exposure Prophylaxis of HIV Infection2 HIV Infections1

Leading sponsors

Gilead Sciences3

Trial status mix

ACTIVE_NOT_RECRUITING2

RECRUITING1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.